CILNIDIPINE-LOADED TRANSDERMAL NANOEMULSION-BASED GEL: SYNTHESIS, OPTIMISATION, CHARACTERISATION, AND PHARMACOKINETIC EVALUATION
DOI:
https://doi.org/10.22159/ijap.2025v17i1.52689Keywords:
Cilnidipine, Pseudo-ternary phase diagram, Transdermal flux, Bioavailability, Pharmacokinetics, Dermal toxicityAbstract
Objective: The aim of the study was to enhance transdermal flux and bioavailability, thereby reforming the effectiveness of drug delivery by synthesising and characterising cilnidipine-loaded nanoemulsion-based gel
Methods: The research was conducted with meticulous planning and execution. After preformulation studies, cilnidipine-loaded nanoemulsions were synthesised using probe sonication and optimised by a 2-factor central composite design. The optimised nanoemulsions were loaded in Carbopol 940 and HPMC K4M gelling system. The optimised nanoemulsions were characterised for droplet size, zeta potential, viscosity, refractive index, pH and TEM, and cilnidipine-loaded nanoemulsion gels were characterised for clarity, homogeneity, consistency, spreadability, extrudability, pH, viscosity, in-vitro diffusion study, dermal toxicity, and pharmacokinetic profiling. The process was accurately planned and accomplished at each step to ensure the precision and reliability of the results.
Results: The findings of this research are not just significant; they are groundbreaking. The steady-state flux values observed ranged from 35.71 ± 1.27 µg/cm²/h to 107.7 ± 2.04 µg/cm²/h for DOE_CiL_1 to 9 and 40.88 ± 1.44 µg/cm²/h to 80.64 ± 1.38 µg/cm²/h for NEn_CiL_GeL_1 to 4. These results underscore the diverse efficacy of different formulations in facilitating drug delivery through the skin. The pharmacokinetics profile of cilnidipine also showed remarkable changes. The Cmax for the cilnidipine tablet was 332.3 ± 14.2 ng/ml, whereas it significantly increased (p<0.05) to 593.00 ± 24.8 ng/ml in the nanoemulsion gel, demonstrating a substantial enhancement in drug concentration. Additionally, the AUC0-12 showed a significant (p<0.05) increase from 1279 ± 34.1 ng/ml.h with the tablet to 1922.50 ± 162.8 ng/ml.h with the nanoemulsion gel. The AUC0-∞ also increased from 1395.5 ± 156.7 ng/ml·h for the tablet to 1962.30 ± 174.9 ng/ml.h for the nanoemulsion gel, further confirming the improved bioavailability of cilnidipine with the nanoemulsion gel. These significant bioavailability improvements cause excitement about the potential impact of this research, which could revolutionise transdermal drug delivery systems in the pharmaceutical business, leading to more effective and efficient drug delivery methods.
Conclusion: The results of this novel study are not only promising but also hold the potential to be transformative. The significant improvement in transdermal flux from the cilnidipine-loaded nanoemulsion gel reveals a substantial increase in the drug's bioavailability. This breakthrough could eliminate several drawbacks of cilnidipine, like first-pass fate and poor solubility, and provide a safer, more convenient delivery method for managing hypertension
Downloads
References
Shete MM. Cilnidipine: Next Generation Calcium Channel Blocker. J Assoc Physicians India. 2016; 64:95.
Chandra KS, Ramesh G. The fourth-generation Calcium channel blocker: Cilnidipine. Indian Heart J. 2013 Dec;65(6):691–5.
Diwan R, Ravi PR, Pathare NS, Aggarwal V. Pharmacodynamic, pharmacokinetic and physical characterization of cilnidipine loaded solid lipid nanoparticles for oral delivery optimized using the principles of design of experiments. Colloids Surf B Biointerfaces. 2020 Sep 1;193.
Renjish C, Ittiyavirah SP, Harindran J, Sudhakaran Nair CR. Preparation, characterisation, evaluation and DFT analysis of Cilnidipine-L-phenylalanine cocrystal. Int J Appl Pharm. 2023 Nov 1;15(6):365–72.
Cherukkoth R, Ittiyavirah SP, Harindran J, Nair CRS. Characterization, evaluation and density functional analysis of Cilnidipine-Otinamide cocrystals developed by liquid assisted grinding technique: A sustainable approach for enhanced solubility. Int J Appl Pharm. 2024 Mar 1;16(2):132–8.
Remya PN, Damodharan N. Formulation, development, and characterisation of cilnidipine loaded solid lipid nanoparticles. Asian J Pharm Clin Res. 2018 Sep 1;11(9):120–5.
Bhalerao A, Chaudhari PP. Formulation of Solid Lipid Nanoparticles of Cilnidipine for the Treatment of Hypertension. J Drug Delivery Ther. 2019 May 15;9(3):212–21.
Mankar SD, Tupe A. Solubility enhancement and evaluation of Cilnidipine using solid Dispersion techniques. International Journal of Experimental Research and Review. 2023; 32:347–57.
Karemore MN, Bali NR. Gellan gum based gastroretentive tablets for bioavailability enhancement of cilnidipine in human volunteers. Int J Biol Macromol. 2021 Mar 31; 174:424–39.
Anand K, Karmakar S, Mandal P, Shaharyar MA, Bhowmik R, Mondal A, Ray S, Karmakar S. Formulation Development, Optimization, and Characterization of Cilnidipine-Loaded Self-microemulsifying Drug Delivery System. Asian Pac J Health Sci [Internet]. 2021; Available from: www.apjhs.com
Khatoon K, Rizwanullah M, Amin S, Mir SR, Akhter S. Cilnidipine loaded transfersomes for transdermal application: Formulation optimization, in-vitro and in-vivo study. J Drug Delivery Sci Technol. 2019 Dec 1;54.
Mishra R, Mir SR, Amin S. Polymeric Nanoparticles for Improved Bioavailability of Cilnidipine. Int J Pharm Pharm Sci. 2017 Feb 27;9(4):129.
Kumar Sharma A, Singh Naruka P, Soni S, Sarangdevot YS, Khandelwal M, Aman S. Development and Evaluation Cilnidipine Fast-Dissolving Tablet by Using Isapghula Husk as Natural Superdisintegrant. Int J Current Pharm Rev Res [Internet]. 2019;11(1):1–11. Available from: http://www.budapestopenaccessinitiative.org/read
Shaikh F, Patel M, Patel V, Patel A, Shinde G, Shelke S, Pathan I. Formulation and optimization of cilnidipine loaded nanosuspension for the enhancement of solubility, dissolution and bioavailability. J Drug Delivery Sci Technol [Internet]. 2022; 69:103066. Available from: https://www.sciencedirect.com/science/article/pii/S1773224721007462
Liu Q, Mai Y, Gu X, Zhao Y, Di X, Ma X, Yang J. A wet-milling method for the preparation of cilnidipine nanosuspension with enhanced dissolution and oral bioavailability. J Drug Delivery Sci Technol. 2020 Feb 1;55.
Alzalzalee RA, Kassab HJ. Cilnidipine Nanoparticles Oral Film: Preparation and Evaluation. Journal of Research in Pharmacy. 2024;28(1):191–6.
Tandel H RKNAUM. Preparation and evaluation of cilnidipine microemulsion. J Pharm Bioallied Sci. 2012 Mar;4(1):114–9.
Sharma A, Singh AP, Harikumar SL. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design. Drug Dev Ind Pharm [Internet]. 2020;46(2):329–42. Available from: http://dx.doi.org/10.1080/03639045.2020.1721527
Gupta A. Chapter 21 - Nanoemulsions. In: Chung EJ, Leon L, Rinaldi C, editors. Nanoparticles for Biomedical Applications [Internet]. Elsevier; 2020. p. 371–84. (Micro and Nano Technologies). Available from: https://www.sciencedirect.com/science/article/pii/B9780128166628000217
Gheorghe I, Saviuc C, Ciubuca B, Lazar V, Chifiriuc MC. Chapter 8 - Nanodrug delivery systems for transdermal drug delivery. In: Grumezescu AM, editor. Nanomater Drug Delivery Ther [Internet]. William Andrew Publishing; 2019. p. 225–44. Available from: https://www.sciencedirect.com/science/article/pii/B9780128165058000102
McClements DJ, Jafari SM. Chapter 1 - General Aspects of Nanoemulsions and Their Formulation. In: Jafari SM, McClements DJ, editors. Nanoemulsions [Internet]. Academic Press; 2018. p. 3–20. Available from: https://www.sciencedirect.com/science/article/pii/B9780128118382000011
Shah MR, Imran M, Ullah S. Chapter 4 - Nanoemulsions. In: Shah MR, Imran M, Ullah S, editors. Lipid-Based Nanocarriers for Drug Delivery and Diagnosis [Internet]. William Andrew Publishing; 2017. p. 111–37. (Micro and Nano Technologies). Available from: https://www.sciencedirect.com/science/article/pii/B9780323527293000044
Figen Tirnaksiz SA and NC. Chapter 9- Nanoemulsions as Drug Delivery Systems. In: Fanun Monzer, editor. Colloids in Drug Delivery. CRC Press., Taylor & Francis Group; 2010. p. 221–44.
Aparna C, Srinivas P, Rao Patnaik KSK. Enhanced transdermal permeability of telmisartan by a novel nanoemulsion gel. Int J Pharm Pharm Sci. 2015;7(4):335–42.
Bali V, Ali M, Ali J. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces. 2010 Apr 1;76(2):410–20.
Patravale V, Borhade V, Pathak S, Sharma S. Clotrimazole nanoemulsion for malaria chemotherapy. Part I: Preformulation studies, formulation design and physicochemical evaluation. Int J Pharm. 2012 Jul 15;431(1–2):138–48.
Chadha R, Bhandari S. Drug-excipient compatibility screening-Role of thermoanalytical and spectroscopic techniques. J Pharm Biomed Anal. 2014 Jan 18; 87:82–97.
Seçilmiş Canbay H, Polat M, Doğantürk M. Study of Stability and Drug-Excipient Compatibility of Estriol. Bilge International Journal of Science and Technology Research. 2019 Sep 30;3(2):102–7.
Hamza MY, Aziz ZRA El, Kassem MA, El-Nabarawi MA. Loxoprofen Nanosponges: Formulation, Characterization and Ex-Vivo Study. Int J Appl Pharm. 2022 Mar 1;14(2):233–41.
Lakavath SK, Ahad HA. Construction Of Ternary Phase Diagram for Three-Component System (Oil-Water-Surfactant) As A Preliminary Step Before Formulating a Nanoemulsion. Eur Chem Bull. 2023;12(10):10669–79.
Jayapal N, Vamshi Vishnu Y. Formulation and in vivo evaluation of self-nanoemulsifying drug delivery system of ramipril in wistar rats. 2021; 14:2021. Available from: http://dx.doi.org/10.22159/ajpcr.2021v14i7.42003.
Modarres-Gheisari SMM, Gavagsaz-Ghoachani R, Malaki M, Safarpour P, Zandi M. Ultrasonic nano-emulsification – A review. Ultrason Sonochem [Internet]. 2019; 52:88–105. Available from: https://www.sciencedirect.com/science/article/pii/S1350417718312690
Zeinali Heris S, Mohamadi Saani S, Abdolalizadeh J. Ultrasonic/sonochemical synthesis and evaluation of nanostructured oil in water emulsions for topical delivery of protein drugs. Ultrason Sonochem. 2019 Jul 1; 55:86–95.
Rahma H, Suciati T. Formulation of Sodium Ascorbyl Phosphate (SAP) In to O/W Nanoemulsion. International Journal of Applied Pharmaceutics. 2023 May 1;15(3):242–6.
Saraswati TS, Roshani R, Damodaran N, Mothilal M, Janani SK. Development of lipid-based vesicles of terbinafine gel for skin delivery by 32full factorial design. Int J Appl Pharm. 2024 Jul 7;231–43.
Deka T, Das MK, Das S, Das P, Singha LR. Box-Behnken Design Approach to Develop Nano-Vesicular Herbal Gel for The Management of Skin Cancer in Experimental Animal Model. Int J Appl Pharm. 2022 Nov 1;14(6):148–66.
Elmataeeshy ME, Sokar MS, Bahey-El-Din M, Shaker DS. Enhanced transdermal permeability of Terbinafine through novel nanoemulgel formulation; Development, in vitro and in vivo characterization. Futur J Pharm Sci. 2018 Jun;4(1):18–28.
Chauhan SB, Naved T, Parvez N. Formulation and development of transdermal drug delivery system of ethinylestradiol and testosterone: In vitro evaluation. Int J Appl Pharm. 2019 Jan 1;11(1):55–60.
Nikumbh K V., Sevankar SG, Patil MP. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen. Drug Deliv. 2015 Jun 1;22(4):509–15.
Shraddha M, Anuradha S. Formulation and evaluation of Emulgel containing Coriandrum sativum seeds oil for Anti-inflammatory activity. J Drug Delivery Ther [Internet]. 2019 Jun 15;9(3-s):124–30. Available from: http://jddtonline.info
Ali EMH, Mahmood S, Sengupta P, Doolaanea AA, Chatterjee B. Sunflower Oil Based Nanoemulsion Loaded into Carbopol Gel: Semisolid State Characterization and Ex Vivo Skin Permeation. Indian J Pharm Sci [Internet]. 2023 Mar 21 [cited 2023 Apr 11];2(2):388–420. Available from: https://www.ijpsonline.com/articles/sunflower-oil-based-nanoemulsion-loaded-into-carbopol-gel-semisolid-state-characterization-and-emex-vivoem-skin-permeation-4924.html
Gaber DA, Alsubaiyel AM, Alabdulrahim AK, Alharbi HZ, Aldubaikhy RM, Alharbi RS, Albishr WK, Mohamed HA. Nano-Emulsion Based Gel for Topical Delivery of an Anti-Inflammatory Drug: In vitro and in vivo Evaluation. Drug Des Devel Ther. 2023; 17:1435–51.
OECD/OCDE 402 OECD Guideline for The Testing of Chemicals. Acute Dermal Toxicity: Fixed Dose Procedure [Internet]. 2017. Available from: http://www.oecd.org/termsandconditions/.
Banerjee S, Chattopadhyay P, Ghosh A, Pathak MP, Singh S, Veer V. Acute dermal irritation, sensitization, and acute toxicity studies of a transdermal patch for prophylaxis against (±) anatoxin-a poisoning. Int J Toxicol. 2013 Jul;32(4):308–13.
Nair A, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27.
Khani S, Keyhanfar F, Amani A. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Drug Deliv. 2016 Jul 23;23(6):2035–43.
Pathan IB, Jaware BP, Shelke S, Ambekar W. Curcumin loaded ethosomes for transdermal application: Formulation, optimization, in-vitro and in-vivo study. J Drug Deliv Sci Technol. 2018 Apr 1; 44:49–57.
Smail SS, Ghareeb MM, Omer HK, Al-Kinani AA, Alany RG. Studies on surfactants, cosurfactants, and oils for prospective use in formulation of ketorolac tromethamine ophthalmic nanoemulsions. Pharmaceutics. 2021 Apr 1;13(467):1–13.
Jadhav CM. Investigating application of non aqueous microemulsion for drug delivery: A review. Asian J Biomed Pharm Sci. 2014 Mar 15;4(29):01–9.
Yadav NP, Rai VK, Mishra N, Yadav KS. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications. J Controlled Release. 2018 Jan 28;270:203–25.
Mou D, Chen H, Du D, Mao C, Wan J, Xu H, Yang X. Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs. Int J Pharm. 2008 Apr 2;353(1–2):270–6.
Published
How to Cite
Issue
Section
Copyright (c) 2024 MAHESH T. GAIKWAD, RAJENDRA P. MARATHE
This work is licensed under a Creative Commons Attribution 4.0 International License.